ARROWHEAD PHARMACEUTICALS, INC. - Common Stock, par value $0.001 per share (ARWR)

CUSIP: 04280A100

Q3 2020 13F Holders as of 30 Sep 2020

Holder snapshot 7 signals
Share change
-414,473
Put/Call ratio
63%
SEC-reported price per share
$43.06
Number of holders
252
Value change
-$17,523,513
Number of buys
110
Open additional details 1 more signal available
Number of sells
117
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
143,396,089

Security key

04280A100

Report period

Q3 2020

Institutions

252

Top holders

10

Ownership snapshot

Top reported holders of ARWR - ARROWHEAD PHARMACEUTICALS, INC. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
BlackRock Finance, Inc.
Disclosed value leader
BlackRock Finance, Inc.
Comparable rows
0/15
Latest evidence
30 Jun 2020
13F Highest disclosed value: $559,524,000 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

BlackRock Finance, Inc. has the largest disclosed position value at $559.52M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens BlackRock Finance, Inc.'s linked filing trail.
Disclosed position value Top 5
BlackRock Finance, Inc. $559.52M
VANGUARD GROUP INC $419.78M
STATE STREET CORP $211.26M
Invesco Ltd. $143.92M
Johnson & Johnson Innovation - JJ... $140.84M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
BlackRock Finance, Inc.
13F
Company
13F
—
denominator unverified
$559,524,000
12,954,928 shares
— 30 Jun 2020
VANGUARD GROUP INC
13F
Company
13F
—
denominator unverified
$419,779,000
9,719,363 shares
— 30 Jun 2020
STATE STREET CORP
13F
Company
13F
—
denominator unverified
$211,262,000
4,891,447 shares
— 30 Jun 2020
Invesco Ltd.
13F
Company
13F
—
denominator unverified
$143,917,000
3,332,194 shares
— 30 Jun 2020
Johnson & Johnson Innovation - JJDC, Inc.
13F
Company
13F
—
denominator unverified
$140,837,000
3,260,869 shares
— 30 Jun 2020
FMR LLC
13F
Company
13F
—
denominator unverified
$119,620,000
2,769,622 shares
— 30 Jun 2020
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2020

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
252
Shares
68,146,322
Rows available
252
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q3 2020 vs Q2 2020 Across Filers

Q2 2020 holders
238
Q3 2020 holders
252
Holder diff
14
Investor Q2 2020 Shares Q3 2020 Shares Share Diff Share Chg % Q2 2020 value Q3 2020 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .